AtriCure, Inc.

Company overview

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, as well as intercostal nerves, to medical centers in the United States, Europe, Asia, and internationally. The company offers the Isolator Synergy Clamp, a single-use disposable radio frequency product, and multifunctional pens and linear ablation devices including the MAX Pen device, which enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device. The Coolrail device allows users to create longer linear ablation lines.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Exchange

NASDAQ

Market cap

$3B

Employees

1,300

Headquarters

Mason, OH

Website

atricure.com

CEO

Michael H. Carrel

Listed

August 5, 2005

P/E

-605.32

Dividend yield

0.00%